What is Columbus McKinnon Corp/NY's earnings per share (EPS)?

Columbus McKinnon Corp/NY (CMCO) reported diluted earnings per share of -$7.40 for fiscal year 2026. This represents a -4011.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Columbus McKinnon Corp/NY (CMCO) Financials

CMCO

Trailing 12 months to June 30, 2026

Revenue $1.5B +55.2% YoY

Net Income -$316.4M -1919.6% YoY

EPS (Diluted) -$9.38 -1637.0% YoY

Free Cash Flow -$122.8M -773.3% YoY

Market Cap $458.9M as of Oct 12, 2026

Price / Sales 0.3x on $1.5B revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 0.3x on $1.4B equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 30, 2026 Reported Jul 30, 2026 Currency USD FYE March

Newest figures come from the 10-Q for Q1 FY2027, filed Jul 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CMCO SEC filings page.

Columbus McKinnon Corp/NY (CMCO) reported $1.5B in revenue over the twelve months to Jun 30, 2026, up 55.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CMCO FY2026 2026-10-04

FY2026 brought much more revenue, but heavier costs, debt, and cash demands overwhelmed the business’s prior operating model.

The central break is growth with weaker unit economics: revenue reached $1.2B while gross margin fell to 30.1%. Operating cash flow moved from $45.6M in FY2025 to -$146.2M in FY2026 while earnings also turned negative, tying the deterioration to cash conversion rather than a purely noncash accounting swing.

Assets jumped from $1.7B in FY2025 to $4.8B in FY2026, a balance-sheet event far larger than the revenue increase. Debt-to-equity rose from 0.5x to 1.5x, so the enlarged asset base is financed with materially more leverage.

SG&A rose from $107M to $178M, making overhead expansion the clearest pressure point. Despite revenue growth of 24.0%, operating margin became negative, showing that the larger sales base was not covering the expanded cost structure.

Financial Health Signals

Financial Health Score 38/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Columbus McKinnon Corp/NY's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Columbus McKinnon Corp/NY has an operating margin of -10.0%, meaning the company loses $10 on every $100 of revenue. This results in a profitability score of 19/100. This is down from 5.7% the prior year.

Growth

Columbus McKinnon Corp/NY's revenue surged 23.9% year-over-year to $1.2B, reflecting rapid business expansion. This strong growth earns a score of 61/100.

Leverage

Columbus McKinnon Corp/NY has a moderate D/E ratio of 1.54. This balance of debt and equity financing earns a leverage score of 37/100.

Liquidity

Columbus McKinnon Corp/NY's current ratio of 2.02 indicates adequate short-term liquidity, earning a score of 59/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Columbus McKinnon Corp/NY's operations used $146.2M of cash, and capex of $17.9M added to the outflow, for a free cash flow shortfall of $164.1M. This results in a cash flow score of 16/100.

Returns

Columbus McKinnon Corp/NY posts a -15.8% return on equity (ROE), meaning it loses $16 for every $100 of shareholders' equity. This results in a returns score of 35/100. This is down from -0.6% the prior year.

Altman Z-Score Distress

0.44

Columbus McKinnon Corp/NY scores 0.44, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak

2/9

Columbus McKinnon Corp/NY passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

Columbus McKinnon Corp/NY reported a net loss of $229.5M while operations used $146.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Columbus McKinnon Corp/NY reported an operating loss of $119.3M against $61.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$531.5M

YoY+125.3%

QoQ+21.4%

5Y CAGR+20.0%

10Y CAGR+13.6%

Columbus McKinnon Corp/NY generated $531.5M in revenue in Q1 2027. This represents an increase of 125.3% from the same quarter a year earlier. Against the prior quarter it is up 21.4%.

EBITDA

$35.5M

YoY+99.9%

QoQ+131.5%

5Y CAGR+10.8%

10Y CAGR+7.5%

Columbus McKinnon Corp/NY's EBITDA was $35.5M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 99.9% from the same quarter a year earlier. Against the prior quarter it is up 131.5%.

Net Income

-$88.7M

YoY-4574.9%

QoQ+62.8%

Columbus McKinnon Corp/NY reported -$88.7M in net income in Q1 2027. This represents a decrease of 4574.9% from the same quarter a year earlier. Against the prior quarter it is up 62.8%.

EPS (Diluted)

-$2.05

QoQ+73.4%

Columbus McKinnon Corp/NY earned -$2.05 per diluted share (EPS) in Q1 2027. Against the prior quarter it is up 73.4%.

Cash & Balance Sheet

Free Cash Flow

$20.0M

YoY+193.4%

QoQ+111.4%

10Y CAGR+21.3%

Columbus McKinnon Corp/NY generated $20.0M in free cash flow in Q1 2027, representing cash available after capex. This represents an increase of 193.4% from the same quarter a year earlier. Against the prior quarter it is up 111.4%.

Cash & Debt

$98.4M

YoY+242.6%

QoQ+1.9%

5Y CAGR+2.1%

10Y CAGR+8.6%

Columbus McKinnon Corp/NY held $98.4M in cash against $2.2B in long-term debt as of Q1 2027.

Shares Outstanding

29M

QoQ+0.1%

5Y CAGR+0.3%

10Y CAGR+3.6%

Columbus McKinnon Corp/NY had 29M shares outstanding in Q1 2027. Against the prior quarter it is up 0.1%.

Dividends Per Share

Not reported for Q1 2027.

Margins & Returns

Gross Margin

27.5%

YoY-5.2pp

QoQ+4.0pp

5Y change-7.2pp

10Y change-4.7pp

Columbus McKinnon Corp/NY's gross margin was 27.5% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is down 5.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.0 percentage points.

Operating Margin

-3.3%

YoY-5.7pp

QoQ+31.7pp

5Y change-8.4pp

10Y change-10.9pp

Columbus McKinnon Corp/NY's operating margin was -3.3% in Q1 2027, reflecting core business profitability. This is down 5.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 31.7 percentage points.

Net Margin

-16.7%

YoY-15.9pp

QoQ+37.7pp

5Y change-13.3pp

10Y change-21.0pp

Columbus McKinnon Corp/NY's net profit margin was -16.7% in Q1 2027, showing the share of revenue converted to profit. This is down 15.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 37.7 percentage points.

Return on Equity

-6.5%

YoY-6.3pp

QoQ+10.0pp

5Y change-5.5pp

10Y change-8.7pp

Columbus McKinnon Corp/NY's ROE was -6.5% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is down 6.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 10.0 percentage points.

Capital Allocation

R&D Spending

$8.5M

YoY+77.2%

QoQ+16.0%

5Y CAGR+19.0%

Columbus McKinnon Corp/NY invested $8.5M in research and development in Q1 2027. This represents an increase of 77.2% from the same quarter a year earlier. Against the prior quarter it is up 16.0%.

Capital Expenditures

$5.7M

YoY+77.0%

QoQ-24.5%

5Y CAGR+9.2%

10Y CAGR+2.8%

Columbus McKinnon Corp/NY invested $5.7M in capex in Q1 2027, funding long-term assets and infrastructure. This represents an increase of 77.0% from the same quarter a year earlier. Against the prior quarter it is down 24.5%.

Share Buybacks

Not reported for Q1 2027.

CMCO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CMCO quarterly income statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Revenue	$1.5B	$1.2B+23.9%	$963.0M-5.0%	$1.0B+8.3%	$936.2M+3.3%	$906.6M+39.5%	$649.6M-19.7%	$809.2M-7.7%	$876.3M+4.4%	$839.4M+31.8%	$637.1M+6.7%	$597.1M+3.0%	$579.6M-0.6%	$583.3M-2.3%	$597.3M+0.9%	$591.9M
Cost of Revenue	$1.1B	$834.0M+30.9%	$637.3M-0.2%	$638.7M+7.5%	$594.1M+0.6%	$590.8M+37.6%	$429.4M-18.4%	$526.0M-7.9%	$571.3M+3.1%	$554.4M+24.8%	$444.2M+8.4%	$409.8M+3.0%	$398.0M-1.0%	$402.2M-4.9%	$423.0M-2.6%	$434.2M
Gross Profit	$428.5M	$359.4M+10.4%	$325.7M-13.1%	$374.8M+9.6%	$342.1M+8.4%	$315.7M+43.4%	$220.2M-22.2%	$283.2M-7.2%	$305.0M+7.0%	$285.1M+47.8%	$192.9M+3.0%	$187.3M+3.1%	$181.6M+0.3%	$181.0M+3.9%	$174.2M+10.5%	$157.7M
R&D Expenses	$25.1M	$21.4M-10.3%	$23.9M-8.9%	$26.2M+25.1%	$20.9M+36.4%	$15.4M+23.7%	$12.4M+9.7%	$11.3M-16.2%	$13.5M-0.9%	$13.6M+29.9%	$10.5M+41.8%	$7.4M+41.0%	$5.2M-4.2%	$5.5M+5.8%	$5.2M+15.0%	$4.5M
SG&A Expenses	$212.9M	$178.3M+66.3%	$107.2M+0.5%	$106.8M+12.6%	$94.8M-7.2%	$102.1M+34.3%	$76.0M-2.4%	$77.9M-6.8%	$83.6M-2.4%	$85.6M+18.7%	$72.1M+17.4%	$61.4M+11.9%	$54.9M-1.6%	$55.8M+6.7%	$52.3M+12.0%	$46.7M
Operating Income	-$142.5M	-$119.3M-318.7%	$54.6M-49.1%	$107.1M+9.5%	$97.8M+32.6%	$73.8M+74.6%	$42.3M-53.0%	$89.8M+29.4%	$69.4M+1.6%	$68.3M+188.0%	$23.7M-41.5%	$40.6M-25.8%	$54.6M+0.5%	$54.4M0.0%	$54.4M+20.4%	$45.1M
EBITDA	N/A	-$42.3M-141.2%	$102.8M-32.9%	$153.1M+9.5%	$139.8M+20.8%	$115.7M+64.3%	$70.4M-40.8%	$119.0M+16.5%	$102.1M-2.2%	$104.5M+113.7%	$48.9M-20.0%	$61.1M-11.7%	$69.2M+2.2%	$67.7M+1.9%	$66.5M+16.6%	$57.0M
Interest Expense	$100.1M	$61.1M+88.6%	$32.4M-14.6%	$38.0M+35.8%	$27.9M+38.8%	$20.1M+66.6%	$12.1M-15.1%	$14.2M-17.0%	$17.1M-13.1%	$19.7M+79.9%	$11.0M+38.7%	$7.9M-36.2%	$12.4M-8.2%	$13.5M-1.9%	$13.8M-3.2%	$14.2M
Income Tax	$43.7M	$22.9M+6348.0%	-$367K-102.5%	$14.9M-42.8%	$26.0M+196.4%	$8.8M+805.8%	$970K-94.5%	$17.5M+69.4%	$10.3M-62.6%	$27.6M+583.2%	$4.0M-66.4%	$12.0M+36.5%	$8.8M-28.3%	$12.3M+134.5%	-$35.7M-617.3%	$6.9M
Net Income	-$316.4M	-$229.5M-4367.4%	-$5.1M-111.0%	$46.6M-3.7%	$48.4M+63.3%	$29.7M+225.7%	$9.1M-84.7%	$59.7M+40.2%	$42.6M+93.0%	$22.1M+145.6%	$9.0M-54.1%	$19.6M-28.0%	$27.2M-10.6%	$30.4M-61.1%	$78.3M+190.3%	$27.0M
EPS (Basic)	N/A	-$7.40-4011.1%	-$0.18-111.1%	$1.62-4.1%	$1.69+59.4%	$1.06+178.9%	$0.38-85.0%	$2.53+38.3%	$1.83+88.7%	$0.97+120.5%	$0.44-55.1%	$0.98-27.9%	$1.36-12.3%	$1.55-61.5%	$4.03+187.9%	$1.40
EPS (Diluted)	-$9.38	-$7.40-4011.1%	-$0.18-111.2%	$1.61-4.2%	$1.68+61.5%	$1.04+173.7%	$0.38-84.8%	$2.50+38.9%	$1.80+89.5%	$0.95+120.9%	$0.43-55.2%	$0.96-28.4%	$1.34-11.8%	$1.52-61.8%	$3.98+188.4%	$1.38
Diluted Shares (Avg)	N/A	29M-0.1%	29M-1.0%	29M+0.7%	29M+1.5%	28M+17.5%	24M+1.3%	24M+0.8%	24M+1.4%	23M+11.7%	21M+2.8%	20M+0.4%	20M+1.4%	20M+1.3%	20M+0.9%	20M

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Revenue	$531.5M+125.3%	$437.8M+77.3%	$258.7M+10.5%	$261.0M+7.7%	$235.9M-1.6%	$246.9M-7.0%	$234.1M-7.9%	$242.3M-6.2%
Cost of Revenue	$385.2M+142.7%	$334.9M+100.5%	$169.5M+11.5%	$170.9M+2.0%	$158.7M+5.3%	$167.1M-2.4%	$152.0M-5.1%	$167.5M+5.7%
Gross Profit	$146.3M+89.4%	$102.9M+28.9%	$89.2M+8.6%	$90.2M+20.6%	$77.2M-13.3%	$79.8M-15.4%	$82.1M-12.6%	$74.7M-25.2%
R&D Expenses	$8.5M+77.2%	$7.4M+17.4%	$4.4M-16.6%	$4.8M-21.6%	$4.8M-21.8%	$6.3M-11.1%	$5.3M-20.4%	$6.1M-6.7%
SG&A Expenses	$65.4M+112.6%	$79.0M+138.1%	$32.1M+32.7%	$36.4M+55.7%	$30.7M+16.2%	$33.2M+21.4%	$24.2M-7.7%	$23.4M-9.1%
Operating Income	-$17.7M-422.2%	-$153.2M-3206.5%	$16.2M-8.6%	$12.2M+12.8%	$5.5M-74.0%	$4.9M-80.6%	$17.7M-34.3%	$10.8M-67.6%
EBITDA	$35.5M+99.9%	-$112.8M-767.7%	$28.3M-5.3%	$24.4M+6.1%	$17.8M-46.2%	$16.9M-54.8%	$29.9M-22.3%	$23.0M-48.8%
Interest Expense	$47.6M+447.4%	$35.4M+334.7%	$8.3M+8.0%	$8.7M+4.7%	$8.7M+5.6%	$8.1M-11.2%	$7.7M-22.6%	$8.4M-18.2%
Income Tax	$21.0M+7993.8%	$22.3M+2860.8%	$1.8M-7.7%	-$1.4M+70.5%	$260K-92.4%	-$809K-132.4%	$1.9M-50.7%	-$4.9M-196.2%
Net Income	-$88.7M-4574.9%	-$238.2M-8775.9%	$6.0M+51.5%	$4.6M+130.5%	-$1.9M-122.0%	-$2.7M-122.7%	$4.0M-59.3%	-$15.0M-195.1%
EPS (Basic)	-$2.05-2828.6%	-$7.70-8455.6%	$0.21+50.0%	$0.16+130.8%	-$0.07-123.3%	-$0.09-122.0%	$0.14-58.8%	-$0.52-194.5%
EPS (Diluted)	-$2.05	-$7.70-8455.6%	$0.21+50.0%	$0.16+130.8%	-$0.07-123.3%	-$0.09-122.0%	$0.14-58.8%	-$0.52-194.5%
Diluted Shares (Avg)	29M	N/A	29M+0.2%	29M0.0%	29M-1.6%	N/A	29M-0.4%	29M-0.5%

CMCO Balance Sheet

CMCO quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$4.8B+175.2%	$1.7B-4.8%	$1.8B+7.5%	$1.7B+0.8%	$1.7B+46.5%	$1.2B+5.2%	$1.1B+3.0%	$1.1B-7.1%	$1.1B+2.6%	$1.1B+44.1%	$772.9M+36.5%	$566.3M-5.4%	$598.7M+5.6%	$566.9M+10.0%	$515.4M
Current Assets	$1.2B+153.5%	$465.8M-9.4%	$514.2M+3.6%	$496.2M+6.4%	$466.6M+5.6%	$441.8M+15.4%	$382.7M+5.6%	$362.6M+0.6%	$360.3M+5.7%	$340.9M+25.0%	$272.7M-0.5%	$274.0M-16.1%	$326.6M+4.0%	$314.0M+5.9%	$296.6M
Cash & Equivalents	$96.6M+79.9%	$53.7M-53.0%	$114.1M-14.3%	$133.2M+15.4%	$115.4M-42.9%	$202.1M+76.6%	$114.5M+61.0%	$71.1M+12.8%	$63.0M-18.8%	$77.6M+50.4%	$51.6M-18.2%	$63.1M-43.9%	$112.3M-7.7%	$121.7M+36.0%	$89.5M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$609.0M+206.7%	$198.6M+6.7%	$186.1M+3.8%	$179.4M+4.2%	$172.1M+54.4%	$111.5M-12.5%	$127.4M-12.9%	$146.3M-4.3%	$152.9M+17.0%	$130.6M+10.7%	$118.0M+14.4%	$103.2M+5.8%	$97.6M+3.6%	$94.2M-12.8%	$108.1M
Accounts Receivable	$380.2M+129.8%	$165.5M-3.3%	$171.2M+13.0%	$151.5M+2.7%	$147.5M+39.9%	$105.5M-14.8%	$123.7M-4.2%	$129.2M+1.1%	$127.8M+14.6%	$111.6M+33.1%	$83.8M+4.1%	$80.5M-13.6%	$93.2M+16.2%	$80.2M-9.5%	$88.6M
Long-Term Investments	$10.2M+1.1%	$10.1M-11.7%	$11.4M+10.4%	$10.4M+0.7%	$10.3M+29.2%	$8.0M+8.8%	$7.3M+4.2%	$7.0M-8.4%	$7.7M-0.2%	$7.7M-57.7%	$18.2M-8.5%	$19.9M-9.5%	$21.9M-8.4%	$24.0M-5.7%	$25.4M
Goodwill	$1.4B+98.2%	$710.8M+0.1%	$710.3M+10.2%	$644.6M-0.7%	$648.8M+95.9%	$331.2M+3.6%	$319.7M-1.0%	$322.8M-7.1%	$347.4M+8.8%	$319.3M+87.0%	$170.7M+40.6%	$121.5M+1.8%	$119.3M+13.2%	$105.4M-1.0%	$106.4M
Total Liabilities	$3.3B+289.4%	$856.7M-9.2%	$943.9M+9.2%	$864.7M-5.3%	$912.9M+47.2%	$620.3M-1.5%	$629.7M-0.1%	$630.4M-14.1%	$734.2M-5.0%	$772.5M+58.8%	$486.5M+63.5%	$297.6M-3.2%	$307.4M-6.0%	$326.9M-7.9%	$354.9M
Current Liabilities	$584.3M+126.6%	$257.9M-1.5%	$261.8M+8.3%	$241.7M-3.2%	$249.6M+35.8%	$183.9M+18.4%	$155.3M-26.5%	$211.3M+2.1%	$207.0M+8.4%	$191.0M+44.1%	$132.5M+36.7%	$97.0M+8.6%	$89.3M+6.0%	$84.2M-18.9%	$103.9M
Non-Current Liabilities	$2.8B+359.6%	$598.8M-12.2%	$682.1M+9.5%	$623.0M-6.1%	$663.3M+52.0%	$436.4M-8.0%	$474.4M+13.2%	$419.1M-20.5%	$527.2M-9.3%	$581.5M+64.3%	$354.0M+76.4%	$200.6M-8.0%	$218.1M-10.1%	$242.6M-3.3%	$251.0M
Long-Term Debt	$2.2B+445.0%	$408.7M-12.5%	$467.3M+11.8%	$418.1M-8.5%	$457.1M+87.0%	$244.5M-1.0%	$246.9M+4.9%	$235.3M-22.4%	$303.2M-17.8%	$368.7M+64.9%	$223.5M+99.7%	$111.9M-25.7%	$150.7M-0.2%	$151.1M-0.6%	$151.9M
Total Equity	$1.4B+64.2%	$882.1M0.0%	$882.1M+5.8%	$833.8M+7.9%	$772.8M+45.8%	$530.1M+14.4%	$463.6M+7.5%	$431.2M+5.6%	$408.2M+19.6%	$341.4M+19.2%	$286.3M+6.5%	$268.7M-7.7%	$291.3M+21.4%	$240.0M+49.6%	$160.5M
Retained Earnings	$135.8M-64.5%	$382.2M-3.3%	$395.3M+10.8%	$356.8M+12.8%	$316.3M+7.7%	$293.8M+1.2%	$290.4M+22.8%	$236.5M+19.5%	$197.9M+10.1%	$179.7M+3.2%	$174.2M+10.4%	$157.8M+17.9%	$133.8M+28.4%	$104.2M+302.4%	$25.9M

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Total Assets	$4.7B+162.7%	$4.8B+175.2%	$1.8B+3.0%	$1.8B-0.4%	$1.8B-0.1%	$1.7B-4.8%	$1.7B-7.9%	$1.8B-2.8%
Current Assets	$1.1B+134.6%	$1.2B+153.5%	$481.9M+9.4%	$480.5M+2.7%	$478.5M0.0%	$465.8M-9.4%	$440.4M-14.7%	$467.7M-8.5%
Cash & Equivalents	$98.4M+242.6%	$96.6M+79.9%	$35.5M-13.9%	$28.0M-49.6%	$28.7M-58.0%	$53.7M-53.0%	$41.2M-60.0%	$55.7M-43.8%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$558.3M+158.2%	$609.0M+206.7%	$222.4M+10.8%	$217.3M+8.1%	$216.2M+7.6%	$198.6M+6.7%	$200.7M-1.8%	$201.0M-1.9%
Accounts Receivable	$373.2M+107.2%	$380.2M+129.8%	$174.3M+11.0%	$179.3M+5.0%	$180.1M+8.0%	$165.5M-3.3%	$157.0M-9.4%	$170.7M+2.6%
Long-Term Investments	$10.3M-0.5%	$10.2M+1.1%	$10.5M-0.9%	$10.4M-1.3%	$10.3M-4.9%	$10.1M-11.7%	$10.6M-14.7%	$10.6M-2.1%
Goodwill	$1.4B+94.0%	$1.4B+98.2%	$731.5M+4.4%	$731.2M+1.8%	$732.4M+3.4%	$710.8M+0.1%	$700.5M-3.8%	$718.0M+0.1%
Total Liabilities	$3.3B+280.9%	$3.3B+289.4%	$839.7M0.0%	$855.3M-2.9%	$868.3M-3.1%	$856.7M-9.2%	$839.3M-14.3%	$880.8M-9.5%
Current Liabilities	$561.9M+116.8%	$584.3M+126.6%	$263.1M+21.1%	$265.9M+15.8%	$259.2M+12.0%	$257.9M-1.5%	$217.3M-19.3%	$229.7M-12.9%
Non-Current Liabilities	$2.7B+350.8%	$2.8B+359.6%	$576.5M-7.3%	$589.3M-9.5%	$609.1M-8.3%	$598.8M-12.2%	$622.0M-12.3%	$651.1M-8.3%
Long-Term Debt	$2.2B+425.7%	$2.2B+445.0%	$399.4M-8.2%	$408.5M-9.2%	$422.8M-8.0%	$408.7M-12.5%	$435.1M-12.9%	$449.9M-12.5%
Total Equity	$1.4B+50.1%	$1.4B+64.2%	$922.9M+5.9%	$914.6M+2.1%	$910.9M+2.8%	$882.1M0.0%	$871.6M-0.8%	$896.1M+4.9%
Retained Earnings	$33.2M-91.3%	$135.8M-64.5%	$386.8M-0.5%	$382.8M-1.0%	$380.3M-5.9%	$382.2M-3.3%	$388.9M+0.3%	$386.9M+1.9%

CMCO Cash Flow Statement

CMCO quarterly cash flow statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	-$102.4M	-$146.2M-420.6%	$45.6M-32.1%	$67.2M-19.7%	$83.6M+71.1%	$48.9M-50.6%	$98.9M-7.4%	$106.8M+34.3%	$79.5M+14.1%	$69.7M+15.2%	$60.5M+14.8%	$52.6M+37.6%	$38.3M+29.6%	$29.5M-30.4%	$42.4M+79.7%	$23.6M
Depreciation & Amortization	N/A	$77.0M+59.9%	$48.2M+4.9%	$45.9M+9.5%	$41.9M+0.1%	$41.9M+48.9%	$28.2M-3.3%	$29.1M-10.9%	$32.7M-9.6%	$36.1M+43.6%	$25.2M+22.6%	$20.5M+41.0%	$14.6M+8.8%	$13.4M+10.4%	$12.1M+2.1%	$11.9M
Stock-Based Compensation	N/A	$9.6M+53.0%	$6.3M-48.0%	$12.0M+15.5%	$10.4M-7.3%	$11.2M+40.2%	$8.0M+78.0%	$4.5M-27.3%	$6.2M+11.0%	$5.6M-5.5%	$5.9M+45.6%	$4.1M+4.3%	$3.9M+7.2%	$3.6M+9.0%	$3.3M+14.5%	$2.9M
Capital Expenditures	$20.3M	$17.9M-16.6%	$21.4M-13.7%	$24.8M+96.4%	$12.6M-3.6%	$13.1M+6.5%	$12.3M+30.4%	$9.4M-23.2%	$12.3M-15.3%	$14.5M+1.0%	$14.4M-35.6%	$22.3M+29.4%	$17.2M-17.3%	$20.8M+40.1%	$14.9M+8.1%	$13.8M
Free Cash Flow	-$122.8M	-$164.1M-777.9%	$24.2M-42.9%	$42.4M-40.3%	$71.0M+98.5%	$35.8M-58.7%	$86.6M-11.1%	$97.4M+44.9%	$67.2M+21.9%	$55.1M+19.7%	$46.1M+52.0%	$30.3M+44.3%	$21.0M+142.6%	$8.7M-68.5%	$27.5M+180.0%	$9.8M
Investing Cash Flow	-$2.5B	-$2.5B-12255.6%	-$19.9M+85.1%	-$133.4M-857.2%	-$13.9M+97.5%	-$554.3M-9891.2%	-$5.5M+44.3%	-$10.0M-500.7%	$2.5M+107.6%	-$32.6M+85.5%	-$224.0M-10.2%	-$203.2M-496.3%	-$34.1M+15.7%	-$40.4M-300.8%	-$10.1M+25.5%	-$13.5M
Financing Cash Flow	$2.6B	$2.7B+3158.8%	-$86.7M-280.0%	$48.2M+196.4%	-$50.0M-111.9%	$420.7M+4229.0%	-$10.2M+80.2%	-$51.6M+23.9%	-$67.8M-13.9%	-$59.5M-131.2%	$190.7M+39.2%	$137.0M+383.1%	-$48.4M-2882.5%	$1.7M+260.1%	-$1.1M-329.1%	$474K
Dividends Paid	$8.1M	$8.0M-0.1%	$8.0M0.0%	$8.0M+0.4%	$8.0M+22.0%	$6.6M+14.5%	$5.7M+1.1%	$5.7M+21.9%	$4.7M+27.2%	$3.7M+10.0%	$3.3M+3.5%	$3.2M+0.4%	$3.2M+303.9%	$792K	N/A	N/A
Share Buybacks	N/A	$0-100.0%	$10.0M	$0-100.0%	$1.0M	$0	$0	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Operating Cash Flow	$25.6M+241.2%	-$166.8M-568.4%	$20.3M+79.0%	$18.4M+96.0%	-$18.2M-68.7%	$35.6M-7.8%	$11.4M-61.0%	$9.4M-43.7%
Depreciation & Amortization	$53.2M+333.7%	$40.4M+238.0%	$12.1M-0.5%	$12.2M+0.3%	$12.3M+3.6%	$12.0M+0.5%	$12.2M+5.5%	$12.2M+5.1%
Stock-Based Compensation	$2.7M+46.4%	N/A	N/A	N/A	$1.8M+67.3%	N/A	N/A	N/A
Capital Expenditures	$5.7M+77.0%	$7.5M+22.2%	$3.8M-26.4%	$3.3M-38.9%	$3.2M-30.8%	$6.1M-27.5%	$5.2M-13.6%	$5.4M+7.8%
Free Cash Flow	$20.0M+193.4%	-$174.3M-691.6%	$16.5M+167.7%	$15.1M+281.9%	-$21.4M-38.8%	$29.5M-2.2%	$6.2M-73.3%	$3.9M-66.1%
Investing Cash Flow	-$5.4M-66.4%	-$2.5B-43132.0%	-$485K+90.9%	-$3.1M+35.7%	-$3.2M+20.4%	-$5.7M+23.4%	-$5.3M+23.4%	-$4.9M+23.3%
Financing Cash Flow	-$21.2M-2072.5%	$2.7B+15660.8%	-$11.8M+45.5%	-$17.7M-2.8%	-$977K+96.8%	-$17.2M+11.9%	-$21.7M-20.2%	-$17.3M+5.1%
Dividends Paid	$2.0M+0.6%	$2.0M+0.4%	$2.0M+0.5%	$2.0M-0.5%	$2.0M-0.6%	$2.0M-0.7%	$2.0M-0.5%	$2.0M+0.5%
Share Buybacks	N/A	$0-100.0%	$0-100.0%	N/A	N/A	$55K	$5.0M	N/A

CMCO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CMCO quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Gross Margin	30.1%-3.7pp	33.8%-3.2pp	37.0%+0.4pp	36.5%+1.7pp	34.8%+0.9pp	33.9%-1.1pp	35.0%+0.2pp	34.8%+0.9pp	34.0%+3.7pp	30.3%-1.1pp	31.4%0.0pp	31.3%+0.3pp	31.0%+1.9pp	29.2%+2.5pp	26.6%
Operating Margin	-10.0%-15.7pp	5.7%-4.9pp	10.6%+0.1pp	10.4%+2.3pp	8.1%+1.6pp	6.5%-4.6pp	11.1%+3.2pp	7.9%-0.2pp	8.1%+4.4pp	3.7%-3.1pp	6.8%-2.6pp	9.4%+0.1pp	9.3%+0.2pp	9.1%+1.5pp	7.6%
Net Margin	-19.2%-18.7pp	-0.5%-5.1pp	4.6%-0.6pp	5.2%+1.9pp	3.3%+1.9pp	1.4%-6.0pp	7.4%+2.5pp	4.9%+2.2pp	2.6%+1.2pp	1.4%-1.9pp	3.3%-1.4pp	4.7%-0.5pp	5.2%-7.9pp	13.1%+8.5pp	4.6%
Return on Equity	-15.8%-15.3pp	-0.6%-5.9pp	5.3%-0.5pp	5.8%+2.0pp	3.8%+2.1pp	1.7%-11.2pp	12.9%+3.0pp	9.9%+4.5pp	5.4%+2.8pp	2.6%-4.2pp	6.8%-3.3pp	10.1%-0.3pp	10.4%-22.2pp	32.6%+15.8pp	16.8%
Return on Assets	-4.8%-4.5pp	-0.3%-2.8pp	2.5%-0.3pp	2.9%+1.1pp	1.8%+1.0pp	0.8%-4.7pp	5.5%+1.5pp	4.0%+2.1pp	1.9%+1.1pp	0.8%-1.7pp	2.5%-2.3pp	4.8%-0.3pp	5.1%-8.7pp	13.8%+8.6pp	5.2%
Current Ratio	2.02+0.2x	1.81-0.2x	1.96-0.1x	2.05+0.2x	1.87-0.5x	2.40-0.1x	2.46+0.7x	1.720.0x	1.740.0x	1.79-0.3x	2.06-0.8x	2.83-0.8x	3.66-0.1x	3.73+0.9x	2.85
Debt-to-Equity	1.54+1.1x	0.46-0.1x	0.530.0x	0.50-0.1x	0.59+0.1x	0.46-0.1x	0.530.0x	0.55-0.2x	0.74-0.3x	1.08+0.3x	0.78+0.4x	0.42-0.1x	0.52-0.1x	0.63-0.3x	0.95
Asset Turnover	0.25-0.3x	0.550.0x	0.560.0x	0.550.0x	0.540.0x	0.56-0.2x	0.74-0.1x	0.83+0.1x	0.73+0.2x	0.57-0.2x	0.77-0.3x	1.020.0x	0.97-0.1x	1.05-0.1x	1.15
FCF Margin	-13.8%-16.3pp	2.5%-1.7pp	4.2%-3.4pp	7.6%+3.6pp	4.0%-9.4pp	13.3%+1.3pp	12.0%+4.4pp	7.7%+1.1pp	6.6%-0.7pp	7.2%+2.2pp	5.1%+1.5pp	3.6%+2.1pp	1.5%-3.1pp	4.6%+2.9pp	1.7%

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Gross Margin	27.5%-5.2pp	23.5%-8.8pp	34.5%-0.6pp	34.5%+3.7pp	32.7%-4.4pp	32.3%-3.2pp	35.1%-1.9pp	30.9%-7.8pp
Operating Margin	-3.3%-5.7pp	-35.0%-37.0pp	6.3%-1.3pp	4.7%+0.2pp	2.3%-6.5pp	2.0%-7.6pp	7.6%-3.0pp	4.5%-8.4pp
Net Margin	-16.7%-15.9pp	-54.4%-53.3pp	2.3%+0.6pp	1.8%+8.0pp	-0.8%-4.4pp	-1.1%-5.5pp	1.7%-2.1pp	-6.2%-12.3pp
Return on Equity	-6.5%-6.3pp	-16.4%-16.1pp	0.7%+0.2pp	0.5%+2.2pp	-0.2%-1.2pp	-0.3%-1.6pp	0.4%-0.7pp	-1.7%-3.5pp
Return on Assets	-1.9%-1.8pp	-5.0%-4.8pp	0.3%+0.1pp	0.3%+1.1pp	-0.1%-0.6pp	-0.1%-0.8pp	0.2%-0.3pp	-0.9%-1.7pp
Current Ratio	2.00+0.2x	2.02+0.2x	1.83-0.2x	1.81-0.2x	1.85-0.2x	1.81-0.2x	2.03+0.1x	2.04+0.1x
Debt-to-Equity	1.63+1.2x	1.54+1.1x	0.43-0.1x	0.45-0.1x	0.46-0.1x	0.46-0.1x	0.50-0.1x	0.50-0.1x
Asset Turnover	0.110.0x	0.09-0.1x	0.150.0x	0.150.0x	0.130.0x	0.140.0x	0.140.0x	0.140.0x
FCF Margin	3.8%+12.8pp	-39.8%-51.8pp	6.4%+3.8pp	5.8%+4.1pp	-9.0%-2.6pp	11.9%+0.6pp	2.6%-6.5pp	1.6%-2.9pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Columbus McKinnon Corp/NY CMCO	FY2026	$1.2B	-$229.5M	-19.2%	$458.9M	38/100
Wabash National Corp. WNC	FY2025	$1.5B	$211.5M	13.7%	$537.7M	37/100
The Manitowoc Company, Inc. MTW	FY2025	$2.2B	$7.2M	0.3%	$781.5M	36/100
Titan International, Inc.(Delaware) TWI	FY2025	$1.8B	-$61.2M	-3.4%	$448.6M	39/100
Hyster-Yale, Inc. HY	FY2025	$3.8B	-$60.1M	-1.6%	$579.9M	30/100
Astec Industries Inc ASTE	FY2025	$1.4B	$38.8M	2.8%	$891.3M	43/100

Where Columbus McKinnon Corp/NY Ranks

Frequently Asked Questions

What is Columbus McKinnon Corp/NY's annual revenue?

Columbus McKinnon Corp/NY (CMCO) reported $1.2B in total revenue for fiscal year 2026. This represents a 23.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Columbus McKinnon Corp/NY's revenue growing?

Columbus McKinnon Corp/NY (CMCO) revenue grew by 23.9% year-over-year, from $963.0M to $1.2B in fiscal year 2026.

Is Columbus McKinnon Corp/NY profitable?

No, Columbus McKinnon Corp/NY (CMCO) reported a net income of -$229.5M in fiscal year 2026, with a net profit margin of -19.2%.

What is Columbus McKinnon Corp/NY's EBITDA?

Columbus McKinnon Corp/NY (CMCO) had EBITDA of -$42.3M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Columbus McKinnon Corp/NY have?

As of fiscal year 2026, Columbus McKinnon Corp/NY (CMCO) had $96.6M in cash and equivalents against $2.2B in long-term debt.

What is Columbus McKinnon Corp/NY's gross margin?

Columbus McKinnon Corp/NY (CMCO) had a gross margin of 30.1% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Columbus McKinnon Corp/NY's operating margin?

Columbus McKinnon Corp/NY (CMCO) had an operating margin of -10.0% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Columbus McKinnon Corp/NY's net profit margin?

Columbus McKinnon Corp/NY (CMCO) had a net profit margin of -19.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does Columbus McKinnon Corp/NY pay dividends?

Yes, Columbus McKinnon Corp/NY (CMCO) paid $0.28 per share in dividends during fiscal year 2026.

What is Columbus McKinnon Corp/NY's return on equity (ROE)?

Columbus McKinnon Corp/NY (CMCO) has a return on equity of -15.8% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Columbus McKinnon Corp/NY's free cash flow?

Columbus McKinnon Corp/NY (CMCO) recorded an outflow of $164.1M in free cash flow during fiscal year 2026. This represents a -777.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Columbus McKinnon Corp/NY's operating cash flow?

Columbus McKinnon Corp/NY (CMCO) recorded an outflow of $146.2M in operating cash flow during fiscal year 2026, representing cash used by core business activities.

What are Columbus McKinnon Corp/NY's total assets?

Columbus McKinnon Corp/NY (CMCO) had $4.8B in total assets as of fiscal year 2026, including both current and long-term assets.

What are Columbus McKinnon Corp/NY's capital expenditures?

Columbus McKinnon Corp/NY (CMCO) invested $17.9M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Columbus McKinnon Corp/NY spend on research and development?

Columbus McKinnon Corp/NY (CMCO) invested $21.4M in research and development during fiscal year 2026.

How many shares does Columbus McKinnon Corp/NY have outstanding?

Columbus McKinnon Corp/NY (CMCO) had 29M shares outstanding as of fiscal year 2026.

What is Columbus McKinnon Corp/NY's current ratio?

Columbus McKinnon Corp/NY (CMCO) had a current ratio of 2.02 as of fiscal year 2026, which is generally considered healthy.

What is Columbus McKinnon Corp/NY's debt-to-equity ratio?

Columbus McKinnon Corp/NY (CMCO) had a debt-to-equity ratio of 1.54 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Columbus McKinnon Corp/NY's return on assets (ROA)?

Columbus McKinnon Corp/NY (CMCO) had a return on assets of -4.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Columbus McKinnon Corp/NY's P/E ratio?

Columbus McKinnon Corp/NY (CMCO) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $458.9M as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Columbus McKinnon Corp/NY's price-to-sales ratio?

Columbus McKinnon Corp/NY (CMCO) trades at 0.3x sales, its market capitalization divided by revenue of $1.5B revenue, trailing 12 months to June 30, 2026. The market capitalization is $458.9M as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does Columbus McKinnon Corp/NY's liquidity compare with its operating cash outflow?

At the end of fiscal year 2026, Columbus McKinnon Corp/NY (CMCO) held $106.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $146.2M over that year. Dividing the one by the other, the reported balance equals about 9 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Columbus McKinnon Corp/NY's Altman Z-Score?

Columbus McKinnon Corp/NY (CMCO) has an Altman Z-Score of 0.44, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Columbus McKinnon Corp/NY's Piotroski F-Score?

Columbus McKinnon Corp/NY (CMCO) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Columbus McKinnon Corp/NY's earnings high quality?

Columbus McKinnon Corp/NY (CMCO) reported a net loss of $229.5M while operations used $146.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Columbus McKinnon Corp/NY cover its interest payments?

Columbus McKinnon Corp/NY (CMCO) reported an operating loss of $119.3M against $61.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Columbus McKinnon Corp/NY?

Columbus McKinnon Corp/NY (CMCO) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.